Open original FDA record ↗Recall record
- FDA identifier
- Z-1109-2008
- Company in FDA record
- Abbott Laboratories Inc.
- FDA classification date
- Mar 19, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Three potential issues with Creatine Kinase Lot Number: 52044HW00: (1) Decrease in quality control and/or patient results (2) An iIncreased imprecision, or (3) Error Code 1054 (Unable to calculate results, Reaction Failure) on Architect cSystems.
Source facts
- Action
- On October 12, 2007, A Product Recall letter was provided to all Clinical Chemistry Creatine Kinase Reagent customers that have received lot number 52044HW00 . Customer reply form were included in all US customers letter. The letter instructed customers to discontinue use of the kits and destroy them following their laboratory procedure, and document the number of kits discarded. Abbott will provide reimbursement for destroyed kits.
- Initiated
- 2007-10-12
- Root cause
- Nonconforming Material/Component
- Terminated
- 2012-03-28
- Distribution
- Worldwide Distribution --- including USA and countries of Canada, Chili, Uruguay, Germany, Hong Kong, and New Zealand.
- Recall number
- Z-1109-2008
- Recall status
- Terminated
- CDRH record ID
- 67350
- FDA classified
- 2008-03-19
- Recall event number
- 46387